TP53 and cancer: CARF was shown to act by multiple mechanisms viz., its (i) direct interactions with proteins including ARF, p53, HDM2, (ii) transcriptional repression of HMD2 and p21WAF131,36 and (iii) promote cancer cell invasion and malignant metastases via epithelial-mesenchymal transition (EMT)37.